Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Zsuzsanna Ament"'
Autor:
Catharine A. Couch, Zsuzsanna Ament, Amit Patki, Naruchorn Kijpaisalratana, Varun Bhave, Alana C. Jones, Nicole D. Armstrong, Mary Cushman, W. Taylor Kimberly, M. Ryan Irvin
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 9 (2024)
Background Sex disparities exist in cardiometabolic diseases. Metabolomic profiling offers insight into disease mechanisms, as the metabolome is influenced by environmental and genetic factors. We identified metabolites associated with sex and determ
Externí odkaz:
https://doaj.org/article/7577f41ff38d48daa218931369b3cbb2
Autor:
Catharine A. Couch, Zsuzsanna Ament, Amit Patki, Naruchorn Kijpaisalratana, Varun Bhave, Alana C. Jones, Nicole D. Armstrong, Katharine L. Cheung, W. Taylor Kimberly, Hemant K. Tiwari, Marguerite Ryan Irvin
Publikováno v:
Nutrients, Vol 16, Iss 15, p 2458 (2024)
The Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) is a hybrid of the Mediterranean and DASH (Dietary Approaches to Stop Hypertension) diets, and its association with renal outcomes remains unclear. In the REasons for Geographic a
Externí odkaz:
https://doaj.org/article/dca93b288696472db3f8753d2f7c5bcc
Autor:
Alana C. Jones, Zsuzsanna Ament, Amit Patki, Ninad S. Chaudhary, Vinodh Srinivasasainagendra, Naruchorn Kijpaisalratana, Devin M. Absher, Hemant K. Tiwari, Donna K. Arnett, W. Taylor Kimberly, Marguerite R. Irvin
Publikováno v:
Frontiers in Genetics, Vol 14 (2023)
Introduction: Metabolic syndrome (MetS) increases the risk of cardiovascular disease and death. Previous ‘-omics’ studies have identified dysregulated serum metabolites and aberrant DNA methylation in the setting of MetS. However, the relationshi
Externí odkaz:
https://doaj.org/article/cdf1fb13f92140d99be9599ae81e8a94
Publikováno v:
BMC Bioinformatics, Vol 17, Iss S15, Pp 37-49 (2016)
Abstract Background The recent pandemic of obesity and the metabolic syndrome (MetS) has led to the realisation that new drug targets are needed to either reduce obesity or the subsequent pathophysiological consequences associated with excess weight
Externí odkaz:
https://doaj.org/article/76b05c5a13d842118f92839eb0e9f75a
Autor:
Zsuzsanna Ament, James A. West, Elizabeth Stanley, Xuefei Li, Tom Ashmore, Lee D. Roberts, Jayne Wright, Andrew W. Nicholls, Julian L. Griffin
Publikováno v:
Data in Brief, Vol 8, Iss , Pp 196-202 (2016)
This article contains mass spectrometry (MS) data investigating small molecule changes as an effect of a triple peroxisome proliferator-activated receptor (PPAR-pan) agonist GW625019 in the liver as described in the manuscript (Ament et al., 2016) [1
Externí odkaz:
https://doaj.org/article/7f227b95d5d14a85aab124682e91c7b2
Autor:
Naruchorn Kijpaisalratana, Zsuzsanna Ament, Amit Patki, Varun M. Bhave, Ana-Lucia Garcia-Guarniz, Suzanne E. Judd, Mary Cushman, D. Leann Long, M. Ryan Irvin, W. Taylor Kimberly
Publikováno v:
Neurology. 100:e2312-e2320
Autor:
Julian L. Griffin, Gerard I. Evan, Trevor Littlewood, Albert Koulman, Tom Ashmore, Deborah L. Burkhart, Catherine H. Wilson, Zsuzsanna Ament, Zoe Hall
Figure legends for supplemental Figures S1-S6.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::459bb0114244c72875e0d65f6ab33318
https://doi.org/10.1158/0008-5472.22410902.v1
https://doi.org/10.1158/0008-5472.22410902.v1
Autor:
Julian L. Griffin, Gerard I. Evan, Trevor Littlewood, Albert Koulman, Tom Ashmore, Deborah L. Burkhart, Catherine H. Wilson, Zsuzsanna Ament, Zoe Hall
Liquid extraction surface analysis mass spectrometry differentiates normal from tumour tissue.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5be781ad5a263dcc5b2ad4b43efb3ed
https://doi.org/10.1158/0008-5472.22410914.v1
https://doi.org/10.1158/0008-5472.22410914.v1
Autor:
Julian L. Griffin, Gerard I. Evan, Trevor Littlewood, Albert Koulman, Tom Ashmore, Deborah L. Burkhart, Catherine H. Wilson, Zsuzsanna Ament, Zoe Hall
MYC-mediated pathogenesis in lung cancer continues to attract interest for new therapeutic strategies. In this study, we describe a transgenic mouse model of KRAS-driven lung adenocarcinoma that affords reversible activation of MYC, used here as a to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c856fd3197712afcbc9dfb3dddd2b2c1
https://doi.org/10.1158/0008-5472.c.6508106.v1
https://doi.org/10.1158/0008-5472.c.6508106.v1
Autor:
Julian L. Griffin, Gerard I. Evan, Trevor Littlewood, Albert Koulman, Tom Ashmore, Deborah L. Burkhart, Catherine H. Wilson, Zsuzsanna Ament, Zoe Hall
LC-MS/MS method details for eicosanoid analysis (Tables S1 and S2); Lipid ID by accurate mass and tandem MS (Tables S3 and S4); Fold change for eicosanoid-related species with MYC activated (Table S5).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f8e9f1fc1d99bd0f466a9dd68b12f9b
https://doi.org/10.1158/0008-5472.22410899
https://doi.org/10.1158/0008-5472.22410899